Display options
Cite
Asgharzadeh MR, Barar J, Pourseif MM, et al. Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy. Bioimpacts. 2017;7(2):115-133doi: 10.15171/bi.2017.15.
Asgharzadeh, M. R., Barar, J., Pourseif, M. M., Eskandani, M., Jafari Niya, M., Mashayekhi, M. R., & Omidi, Y. (2017). Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy. BioImpacts : BI, 7(2), 115-133. https://doi.org/10.15171/bi.2017.15
Asgharzadeh, Mohammad Reza, et al. "Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy." BioImpacts : BI vol. 7,2 (2017): 115-133. doi: https://doi.org/10.15171/bi.2017.15
Asgharzadeh MR, Barar J, Pourseif MM, Eskandani M, Jafari Niya M, Mashayekhi MR, Omidi Y. Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy. Bioimpacts. 2017;7(2):115-133. doi: 10.15171/bi.2017.15. Epub 2017 Jun 07. PMID: 28752076; PMCID: PMC5524986.
Copy Download .nbib Format: NLM
Share it on

Bioimpacts. 2017;7(2):115-133. doi: 10.15171/bi.2017.15. Epub 2017 Jun 07.

Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy.

BioImpacts : BI

Mohammad Reza Asgharzadeh, Jaleh Barar, Mohammad M Pourseif, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi

Affiliations

  1. Department of Biology, Fars Science and Research Branch, Islamic Azad University, Marvdasht, Iran.
  2. Department of Biology, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran.
  3. Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
  4. Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
  5. Department of Genetic, Tabriz Branch, Islamic Azad University, Tabriz, Iran.

PMID: 28752076 PMCID: PMC5524986 DOI: 10.15171/bi.2017.15

[No abstract available.]

Keywords: Cancer; Carbonic anhydrases; Hypoxia; Sodium-hydrogen exchanger; Synthetic lethality; Targeted therapy of cancer; Tumor microenvironment; Vacuolar-type H+-ATPase; pH dysregulation

References

  1. J Nanobiotechnology. 2015 Mar 26;13:26 - PubMed
  2. Exp Cell Res. 2011 Aug 15;317(14):2031-40 - PubMed
  3. Biochemistry. 2006 Feb 21;45(7):2414-24 - PubMed
  4. Clin Cancer Res. 2007 Sep 1;13(17):5020-7 - PubMed
  5. J Biol Chem. 2015 Feb 6;290(6):3680-92 - PubMed
  6. Stem Cells. 2007 Mar;25(3):807-15 - PubMed
  7. Hum Antibodies. 2009;18(3):81-100 - PubMed
  8. Oncogene. 2015 Oct 1;34(40):5163-74 - PubMed
  9. Colloids Surf B Biointerfaces. 2013 Jun 1;106:117-25 - PubMed
  10. Clin Cancer Res. 2012 Jun 1;18(11):3100-11 - PubMed
  11. J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6 - PubMed
  12. Nat Genet. 2000 Sep;26(1):71-5 - PubMed
  13. Eur J Cancer. 2005 Dec;41(18):2935-47 - PubMed
  14. Biochemistry. 2003 Jun 24;42(24):7448-56 - PubMed
  15. Semin Radiat Oncol. 2004 Jul;14(3):198-206 - PubMed
  16. Exp Cell Res. 2003 Nov 1;290(2):332-45 - PubMed
  17. Nat Cell Biol. 2000 Jun;2(6):318-25 - PubMed
  18. J Biochem. 2003 Sep;134(3):359-64 - PubMed
  19. J Biol Chem. 2003 Nov 7;278(45):44645-9 - PubMed
  20. J Biol Chem. 2003 Apr 4;278(14 ):11828-35 - PubMed
  21. Cancer Res. 1989 Aug 15;49(16):4373-84 - PubMed
  22. Cancer Treat Rev. 2009 Dec;35(8):707-13 - PubMed
  23. Bioimpacts. 2014;4(2):55-67 - PubMed
  24. J Cell Biol. 2000 Jul 10;150(1):213-24 - PubMed
  25. Drug Resist Updat. 2016 Jan;24:23-33 - PubMed
  26. Int J Cancer. 2013 Aug 15;133(4):843-54 - PubMed
  27. EMBO J. 2011 Jul 29;30(16):3242-58 - PubMed
  28. Int J Oncol. 2009 Jun;34(6):1513-20 - PubMed
  29. Bioorg Med Chem. 2008 Oct 1;16(19):8781-94 - PubMed
  30. Genes Dev. 2007 Sep 15;21(18):2283-7 - PubMed
  31. Bioimpacts. 2016;6(3):169-181 - PubMed
  32. Cell Death Differ. 2011 May;18(5):829-40 - PubMed
  33. J Cell Biol. 1995 Aug;130(3):503-6 - PubMed
  34. Anticancer Drug Des. 1999 Apr;14(2):169-77 - PubMed
  35. Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):554-63 - PubMed
  36. Cancer Res. 2001 Jul 1;61(13):5215-22 - PubMed
  37. Biochim Biophys Acta. 2013 May;1832(5):606-17 - PubMed
  38. Nat Commun. 2014 Nov 04;5:5232 - PubMed
  39. Mol Cancer Ther. 2014 Apr;13(4):926-37 - PubMed
  40. Bioimpacts. 2015;5(3):117-22 - PubMed
  41. J Biol Chem. 1995 Jan 20;270(3):1230-7 - PubMed
  42. Oncotarget. 2014 Mar 15;5(5):1162-73 - PubMed
  43. Expert Opin Ther Targets. 2013 Mar;17(3):281-91 - PubMed
  44. J Drug Target. 2017 Mar;25(3):202-215 - PubMed
  45. Cancer Res. 2013 Feb 15;73(4):1259-64 - PubMed
  46. Asian Pac J Cancer Prev. 2013;14(1):495-8 - PubMed
  47. J Biol Chem. 2010 Jan 1;285(1):381-91 - PubMed
  48. Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):29-40 - PubMed
  49. Mol Cell. 2000 Dec;6(6):1425-36 - PubMed
  50. Cancer Res. 2000 May 1;60(9):2497-503 - PubMed
  51. J Biol Chem. 2002 Nov 15;277(46):43771-7 - PubMed
  52. Nature. 2012 Jul 26;487(7408):505-9 - PubMed
  53. Acta Biomater. 2014 Apr;10(4):1558-70 - PubMed
  54. Genes Dev. 2011 Dec 1;25(23):2465-79 - PubMed
  55. Biochemistry. 1995 Aug 22;34(33):10412-20 - PubMed
  56. Front Physiol. 2013 Oct 01;4:271 - PubMed
  57. Int J Cancer. 2003 Jul 20;105(6):873-81 - PubMed
  58. Cell Biol Int. 2012 Aug 1;36(8):739-45 - PubMed
  59. Cell Cycle. 2013 Jun 1;12 (11):1791-801 - PubMed
  60. J Biol Chem. 2000 Mar 24;275(12):8760-5 - PubMed
  61. Biochemistry. 1997 Oct 21;36(42):12854-61 - PubMed
  62. Med Res Rev. 2015 Mar;35(2):408-36 - PubMed
  63. Cancer Res. 2001 Apr 1;61(7):2878-84 - PubMed
  64. Clin Exp Metastasis. 1999;17(10):799-808 - PubMed
  65. Am J Physiol. 1992 Nov;263(5 Pt 2):F833-40 - PubMed
  66. Pflugers Arch. 2009 Sep;458(5):981-92 - PubMed
  67. Biochem Biophys Res Commun. 2013 May 17;434(4):773-8 - PubMed
  68. Mol Pharmacol. 2005 Dec;68(6):1699-707 - PubMed
  69. J Pathol. 2008 Jan;214(1):25-37 - PubMed
  70. Trends Pharmacol Sci. 2006 Nov;27(11):566-73 - PubMed
  71. J Theor Biol. 2010 Dec 7;267(3):461-70 - PubMed
  72. Int J Biol Macromol. 2017 Jun;99:46-62 - PubMed
  73. Clin Chem. 2013 Jan;59(1):85-93 - PubMed
  74. FEBS J. 2015 May;282(9):1801-14 - PubMed
  75. Cell Cycle. 2007 Jan 1;6(1):60-4 - PubMed
  76. J Med Chem. 2010 Jan 14;53(1):335-44 - PubMed
  77. Mol Cell Endocrinol. 2002 Feb 22;187(1-2):39-45 - PubMed
  78. Mol Cancer Res. 2011 Jul;9(7):845-55 - PubMed
  79. J Cell Physiol. 2005 Mar;202(3):654-62 - PubMed
  80. Cancer Metastasis Rev. 2013 Jun;32(1-2):303-15 - PubMed
  81. Glycobiology. 2009 Aug;19(8):890-8 - PubMed
  82. Int J Oral Maxillofac Surg. 2012 Oct;41(10 ):1206-10 - PubMed
  83. Cancer Res. 2014 Dec 15;74(24):7453-64 - PubMed
  84. J Natl Cancer Inst. 2001 Feb 21;93(4):266-76 - PubMed
  85. Cancer Metastasis Rev. 1989 Aug;8(2):98-101 - PubMed
  86. J Nanobiotechnology. 2012 Jan 05;10:2 - PubMed
  87. Curr Mol Med. 2012 Sep;12(8):1068-82 - PubMed
  88. Clin Cancer Res. 2002 Apr;8(4):1284-91 - PubMed
  89. Nat Rev Cancer. 2013 Oct;13(10):714-26 - PubMed
  90. EMBO J. 1998 Aug 17;17(16):4712-22 - PubMed
  91. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4102-6 - PubMed
  92. Cancer Cell. 2011 Sep 13;20(3):370-83 - PubMed
  93. Curr Cancer Drug Targets. 2008 Dec;8(8):720-32 - PubMed
  94. Cancer Res. 2012 Nov 15;72(22):5976-87 - PubMed
  95. Lab Invest. 2011 May;91(5):732-43 - PubMed
  96. Mol Cell Biol. 2001 Nov;21(22):7545-57 - PubMed
  97. Hypertension. 1991 Jan;17(1):8-14 - PubMed
  98. Cancer Cell. 2011 Jun 14;19(6):776-91 - PubMed
  99. FEBS Lett. 2004 Nov 19;577(3):439-45 - PubMed
  100. Expert Rev Anticancer Ther. 2004 Dec;4(6):1113-24 - PubMed
  101. J Biol Chem. 2013 Jan 11;288(2):1385-96 - PubMed
  102. Science. 2015 Apr 3;348(6230):74-80 - PubMed
  103. Front Pharmacol. 2012 Jul 17;3:140 - PubMed
  104. Onco Targets Ther. 2013 Nov 25;6:1729-35 - PubMed
  105. Genes Cells. 2011 Apr;16(4):416-26 - PubMed
  106. Am J Physiol. 1999 Feb;276(2 Pt 2):H709-17 - PubMed
  107. Commun Integr Biol. 2011 Mar;4(2):182-5 - PubMed
  108. Oncotarget. 2015 Jul 30;6(21):18406-17 - PubMed
  109. Mol Oncol. 2015 Feb;9(2):377-88 - PubMed
  110. J Biol Chem. 2001 May 11;276(19):15794-800 - PubMed
  111. EMBO J. 1993 Dec 15;12(13):5209-18 - PubMed
  112. Radiother Oncol. 2011 Jun;99(3):424-31 - PubMed
  113. J Clin Invest. 2006 Jul;116(7):1955-62 - PubMed
  114. Tumour Biol. 2014 May;35(5):3945-51 - PubMed
  115. Cancer Cell. 2008 Jun;13(6):472-82 - PubMed
  116. Cell Struct Funct. 1993 Jun;18(3):139-49 - PubMed
  117. Nat Med. 1999 Jun;5(6):662-8 - PubMed
  118. Front Physiol. 2014 Apr 16;5:130 - PubMed
  119. Cancer Res. 2009 Jan 1;69(1):358-68 - PubMed
  120. Pharmacol Rev. 2009 Jun;61(2):198-223 - PubMed
  121. Bioimpacts. 2014;4(1):3-14 - PubMed
  122. Curr Opin Cell Biol. 2002 Oct;14(5):608-16 - PubMed
  123. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3467-74 - PubMed
  124. Bioimpacts. 2013;3(4):149-62 - PubMed
  125. Int J Cancer. 2001 Jan 1;91(1):120-5 - PubMed
  126. Carcinogenesis. 2009 Jul;30(7):1073-81 - PubMed
  127. Future Med Chem. 2011 Jul;3(9):1165-80 - PubMed
  128. EMBO J. 2005 Jul 20;24(14):2499-511 - PubMed
  129. Cancer Treat Rev. 2003 Dec;29(6):541-9 - PubMed
  130. Bioimpacts. 2014;4(3):149-66 - PubMed
  131. Nat Rev Cancer. 2011 Aug 11;11(9):671-7 - PubMed
  132. N Engl J Med. 2001 Mar 15;344(11):783-92 - PubMed
  133. Oncotarget. 2014 Mar 15;5(5):1253-64 - PubMed
  134. Cancer Microenviron. 2012 Apr;5(1):5-18 - PubMed
  135. J Cell Physiol. 1998 May;175(2):141-8 - PubMed
  136. Curr Opin Immunol. 2011 Apr;23(2):265-71 - PubMed
  137. Pflugers Arch. 2004 Feb;447(5):549-65 - PubMed
  138. Am J Physiol Cell Physiol. 2004 Jun;286(6):C1443-52 - PubMed
  139. Oncotarget. 2015 Sep 29;6(29):28057-70 - PubMed
  140. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1732-5 - PubMed
  141. J Cancer Res Clin Oncol. 2002 Oct;128(10 ):561-8 - PubMed
  142. Blood. 2012 May 24;119(21):5048-56 - PubMed
  143. BioDrugs. 2013 Feb;27(1):55-67 - PubMed
  144. Science. 2009 May 22;324(5930):1029-33 - PubMed
  145. Cell. 2009 Nov 25;139(5):891-906 - PubMed
  146. Cancer Res. 2014 Mar 1;74(5):1598-608 - PubMed
  147. N Engl J Med. 2007 Jan 18;356(3):227-36 - PubMed
  148. Biochim Biophys Acta. 2010 Feb;1804(2):374-81 - PubMed
  149. Am J Physiol Cell Physiol. 2011 Aug;301(2):C280-8 - PubMed
  150. Onco Targets Ther. 2014 Oct 20;7:1933-44 - PubMed
  151. ISRN Biochem. 2014 Apr 10;2014:351959 - PubMed
  152. Colloids Surf B Biointerfaces. 2016 Jul 1;143:224-32 - PubMed
  153. Can J Physiol Pharmacol. 2006 Nov;84(11):1081-95 - PubMed
  154. Int J Nanomedicine. 2014 Apr 15;9:1855-70 - PubMed
  155. Cancer Res. 2011 May 1;71(9):3364-76 - PubMed
  156. FASEB J. 2010 Oct;24(10):3903-15 - PubMed
  157. Expert Rev Hematol. 2009 Dec;2(6):649-62 - PubMed
  158. Pathol Oncol Res. 2012 Apr;18(2):413-20 - PubMed
  159. Bioimpacts. 2013;3(2):49-51 - PubMed
  160. Drug Dev Ind Pharm. 2017 Aug;43(8):1283-1291 - PubMed
  161. J Transl Med. 2013 Nov 06;11:282 - PubMed
  162. Nat Rev Cancer. 2003 Jun;3(6):453-8 - PubMed
  163. J Biomed Nanotechnol. 2010 Aug;6(4):360-9 - PubMed
  164. Front Immunol. 2016 Feb 16;7:52 - PubMed
  165. Drug Dev Ind Pharm. 2017 Aug;43(8):1244-1253 - PubMed
  166. Amino Acids. 2013 Jan;44(1):25-32 - PubMed
  167. Cancer Metastasis Rev. 1994 Jun;13(2):121-38 - PubMed
  168. J Drug Target. 2016;24(2):120-33 - PubMed
  169. Trends Biochem Sci. 2015 Oct;40(10 ):611-22 - PubMed
  170. Science. 2009 Nov 27;326(5957):1216-9 - PubMed
  171. World J Urol. 2011 Feb;29(1):121-6 - PubMed
  172. Mol Cancer Ther. 2006 May;5(5):1275-9 - PubMed
  173. Annu Rev Pharmacol Toxicol. 2002;42:527-52 - PubMed
  174. J Exp Biol. 1992 Nov;172:149-53 - PubMed
  175. Bioimpacts. 2011;1(3):145-7 - PubMed
  176. J Am Chem Soc. 2008 Dec 3;130(48):16130-1 - PubMed
  177. BMC Med. 2015 Mar 05;13:45 - PubMed
  178. Nat Rev Drug Discov. 2011 Sep 16;10(10):767-77 - PubMed

Publication Types